Why an analyst bullish on Gilead says antiviral drug ‘won’t solve’ COVID-19
April 17, 2020 at 06:09 AM EDT
“Did remdesivir just ‘solve’ COVID? No,” says Umer Raffat, an analyst at Evercore ISI.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|